SUMO Modifies GβL and Mediates mTOR Signaling

Published: Sept. 3, 2020, 5:01 a.m.

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.09.03.281881v1?rss=1 Authors: Park, S. L. L., Ramirez Jarquin, U. N., Shahani, N., Rivera, O., Sharma, M., McManus, F. P., Thibault, P., Subramaniam, S. Abstract: The mechanistic target of rapamycin (mTOR) signaling is influenced by multiple regulatory proteins and post-translational modifications, however, underlying mechanisms remains unclear. Here, we report a novel role of small ubiquitin-like modifier (SUMO) in mTOR complex assembly and activity. By investigating the SUMOylation status of core mTOR components, we observed that the regulatory subunit, G{beta}L, is modified by SUMO1, 2, and 3 isoforms. Using mutagenesis and mass spectrometry, we identified that G{beta}L is SUMOylated at lysine sites K86, K215, K245, K261 and K305. We found that SUMO depletion reduces mTOR-Raptor and mTOR-Rictor complex formation and diminishes nutrient-induced mTOR signaling. Furthermore, we found that reconstitution with WT G{beta}L but not SUMOylation defective KR mutant G{beta}L promote mTOR signaling in G{beta}L-depleted cells. Taken together, we report for the very first time that SUMO modifies G{beta}L, influences the assembly of mTOR protein complexes, and regulates mTOR activity. Copy rights belong to original authors. Visit the link for more info